European expert consensus statement on the systemic treatment of alopecia areata
Medical University of Warsaw · Charles University · +15 more institutions
Abstract
Alopecia areata is an autoimmune form of non-scarring hair loss. It is usually characterized by limited areas of hair loss. However, the disease may progress to complete scalp and body hair loss (alopecia totalis, alopecia universalis). In patients with alopecia areata hair loss significantly impacts the quality of life. Children and adolescents with alopecia areata often experience bullying, including physical aggression. The disease severity evaluation tools used in clinical practice are: the Severity of Alopecia Tool (SALT) score and the Alopecia Areata Scale (AAS). A SALT score equal to or greater than 20 constitutes a commonly accepted indication for systemic therapy in alopecia areata. When using the…
Citation impact
- FWCI
- 54.67
- Percentile
- 100%
- References
- 50
Authors
17- LRLidia Rudnicka
Medical University of Warsaw
- MAMonika Arenbergerová
Charles University, University Hospital Kralovske Vinohrady
- RGRamón Grimalt
Universitat Internacional de Catalunya
- DID. Ioannides
Aristotle University of Thessaloniki
- AKAlexander Katoulis
National and Kapodistrian University of Athens, University General Hospital Attikon
Topics & keywords
- Alopecia areata
- Alopecia universalis
- Medicine
- Hair loss
- Dermatology
- Minoxidil
- Scalp
- Good health and well-being